German Hospital Reform 2025

German Hospital Reform 2025 marks a fundamental shift in how hospitals secure DRG eligibility, structure their service portfolios, and stabilise their finances. For more than two decades, the German DRG system rewarded activity: if a hospital coded correctly, documented severity, and survived MD scrutiny, it could bill the DRG and use that revenue to cross-subsidise other parts of the organisation. Under this model, reimbursement followed volume, not structural capability. Hospitals optimised for case mix index, DRG profitability, and length-of-stay incentives, even when demographic change, workforce shortages, and capital under-investment made that behaviour increasingly unsustainable.

With German Hospital Reform 2025, that logic is deliberately reversed. Instead of asking “what DRGs can we bill?”, hospitals must first ask “which services are we structurally allowed to deliver?”. The reform introduces Leistungsgruppen and a structural capability framework that link DRG eligibility to minimum volumes, specialist availability, equipment standards, and integration into regional care networks. Reimbursement now flows to institutions that can demonstrate verifiable competence for specific categories of care, rather than to any hospital capable of submitting a valid DRG claim. In economic terms, Germany is moving from activity-based reimbursement to capability-based reimbursement, changing not only who can access DRG income, but also where innovation, investment, and complex clinical activity will concentrate over the next decade.

German hospital reform 2025 has triggered the most significant transformation in Germany’s hospital financing model in more than two decades. For years, the German DRG system shaped incentives, clinical behaviour, capital allocation, and revenue strategy across the hospital sector. But under the new structural-capability model introduced on 1 January 2025, hospitals are no longer reimbursed simply for coded activity; they must demonstrate structural competence, staffing, equipment, minimum volumes, and integrated regional capability in order to access many DRGs.

Germany’s Krankenhausreform 2025 represents the most far-reaching transformation of hospital financing since the introduction of DRGs in 2003. For two decades, the German DRG system acted as the dominant economic engine of hospital behaviour: reimbursement flowed according to coded activity, not structural capability or long-term system efficiency. The G-BA determined scientific benefit, IQWiG evaluated the strength of clinical evidence, and InEK priced individual hospital cases through the annual DRG catalogue. Hospitals therefore optimised their service mix based on case numbers, case mix index (CMI), length of stay incentives, and DRG profitability, rather than on regional need, structural quality, or outcome equity.

By 2020–2024, the limitations of this activity-based model had become undeniable. Germany had one of the highest hospital densities in Europe, but persistent variation in outcomes, duplication of services, rising specialist shortages, and insufficient concentration of high-complexity care. Economically, the DRG system rewarded volume growth, even when demographic pressures and constrained staffing made this unsustainable. Financial stress intensified: more than half of German hospitals reported structural deficits, while Länder investment funding failed to match capital requirements—forcing hospitals to depend even more heavily on DRG-driven revenue gaming.

This context explains why the logic of financing changed so abruptly on 1 January 2025.

Under the new German hospital reform 2025, reimbursement is no longer determined solely by a hospital’s ability to document and code a DRG. Instead, payment depends on whether the institution can demonstrate the structural capability required to deliver the service safely and at sufficient quality. This includes minimum volumes, workforce availability, infrastructure readiness, cross-sector coordination, and participation in regional care networks.

In economic terms, Germany has shifted from activity-based reimbursement to capability-based reimbursement. This transition resets incentives across the entire hospital landscape:

It discourages inefficient duplication of complex services.
It concentrates scarce specialists in higher-capability centres.
It reduces future insolvency risk by aligning service portfolios with structural reality.
It ties financial flows to verified institutional competence rather than case inflation.

This is not a marginal update; it is a recalibration of the national production function for hospital care. The reform redirects billions of euros in future reimbursement streams and reshapes where innovation, investment, and clinical complexity will be located. For medtech, diagnostics, and digital health innovators, the reform fundamentally alters the economic geography of the German market: value will now be captured primarily in hospitals that meet the new Leistungsgruppen requirements, while others transition towards lower-acuity roles.

The introduction of structural capability governance is therefore the most consequential shift in German healthcare financing in more than 20 years, not simply a change in coding logic, but a restructuring of the economic incentives that determine how, where, and by whom care is delivered.

What Are Leistungsgruppen? The Core Mechanism of the German Hospital Reform 2025

A defining component of the German hospital reform 2025 is the introduction of Leistungsgruppen—structured service groups that determine which hospitals are permitted to deliver specific categories of care. This marks a clear departure from the legacy DRG philosophy, where any hospital could perform a procedure as long as it coded the DRG correctly. Under the new model, eligibility precedes activity.

The reform reorganises hospitals into three structural tiers:

Level I – Basic Care (Grundversorgung): low-complexity, high-volume, general acute services
Level II – Advanced/Intermediate Care (erweiterte Versorgung): multidisciplinary services with defined specialist availability
Level III – Specialised/Maximum Care (Maximalversorgung): the highest structural and clinical capability, typically university hospitals and major regional centres

To be accredited for a specific Leistungsgruppe, a hospital must demonstrate a verifiable structural capability profile, including:

Minimum procedural volumes supported by outcome-based evidence
Continuous specialist availability, often 24/7 for acute pathways
Defined equipment and infrastructure standards (e.g., cath labs, ICU capacity, imaging modalities)
Multidisciplinary clinical integration, consistent with modern care pathways
24/7 emergency capability where required by the clinical category
Participation in regional care networks, ensuring coordinated patient flow and referral logic

These requirements are grounded in health-services research. According to the WHO European Observatory (HSPM Germany, 2025), the reform shifts Germany from an activity-based financing model to a structural-capability governance model, where reimbursement is permitted only when hospitals meet objectively validated structural criteria. This transition addresses longstanding concerns about duplication of services, outcome variability, and inefficiency arising from a dispersed hospital landscape.

The approach closely mirrors Scandinavian and Dutch health-system design, where capability determines eligibility, not billing codes. In these systems now influencing German policy, high-complexity care is concentrated in structurally capable centres, improving outcomes, stabilising workforce allocation, and aligning financing with real institutional competence.

In practical terms, Leistungsgruppen become the new gatekeepers of DRG access, redefining who can deliver which services under the German hospital reform 2025.

What This Means for DRGs: DRGs Do Not Grant Eligibility Grants DRGs

For two decades, the German DRG system operated on a simple principle:
if a hospital coded correctly, documented appropriately, and passed MD (Medizinischer Dienst) audit scrutiny, it could bill the DRG. The underlying assumption was that activity implied capability.

This assumption is now fundamentally reversed under the German hospital reform 2025.

Under the pre-2025 DRG logic:

If ICD and OPS codes matched the DRG definitions,
If clinical documentation demonstrated acuity and complexity,
If MD audits validated completeness and necessity,

→ the hospital was financially entitled to the DRG, regardless of whether its structural capability matched the complexity of the service.

This created predictable distortions:

Economically marginal hospitals expanded into complex services to chase DRG revenue.
Overcapacity emerged in high-cost specialties such as cardiology and orthopaedics.
Outcome variation persisted because structural capability was unevenly distributed.
The DRG incentive structure encouraged volume maximisation over system-level efficiency.

From 2025 onward: the logic flips.

A hospital can only bill a given DRG if it holds the corresponding Leistungsgruppe, meaning it has demonstrated:

verified structural capacity,
continuous specialist availability,
minimum procedural volumes supported by outcome evidence,
and integrated participation in regional care networks.

This transformation has profound economic and financial consequences:

1. High-complexity DRGs will consolidate into structurally capable centres

Services such as:

interventional cardiology,
complex oncology,
major trauma care,
high-end orthopaedic reconstruction,
neurocritical care

will increasingly migrate into Level II and III centres, which are the only institutions capable of meeting the Leistungsgruppen criteria.

This consolidates both revenue streams and clinical expertise.

2. Smaller hospitals will lose access to many profitable DRGs

Hospitals unable to meet structural capability thresholds will:

lose eligibility for high-margin DRGs,
shift their revenue base to lower-acuity DRGs,
concentrate on geriatric, rehabilitation, chronic disease, and palliative pathways,
experience tighter operating margins because their DRG mix becomes less profitable.

This is a direct economic redistribution of DRG revenue:
capability, not case volume, now determines financial viability.

3. The innovation market narrows—but its value density increases

Under the old system, innovators attempted national deployment.
Under the new system:

The number of eligible hospitals shrinks.
The case density per eligible hospital increases.
Adoption becomes deeper, more integrated, and more strategically anchored.

For medtech, diagnostics, and digital health companies, the addressable market is now structurally defined, not geographically defined.

A product’s market is now:

not “all hospitals in Germany,”
but “all hospitals holding Leistungsgruppe X.”

This radically alters sales strategy, staffing, evidence deployment, post-market evaluation, and contracting logic.

4. DRG revenue becomes conditional on structural compliance

Hospitals risk DRG revenue loss if they fail to maintain qualification standards.
This forces ongoing investment in:

workforce retention,
infrastructure renewal,
digital integration,
quality assurance systems,
minimum-volume compliance.

From a financial perspective, Leistungsgruppen become a new class of capital requirement.

Hospitals that fail to invest will:

lose access to high-value DRGs,
enter negative spiral cash-flow patterns,
face consolidation or service downgrading.

5. Regionalisation of care introduces a new economic geography

The reform shifts Germany closer to the Dutch and Scandinavian models, where:

high-complexity care is concentrated,
resources are allocated efficiently,
workforce shortages are mitigated by clustering expertise,
and financing aligns with outcome-oriented structures.

This realignment redistributes:

patient flows,
capital investment,
innovation diffusion,
and the strategic role of hospitals in regional ecosystems.

6. For innovators: market access now depends on structural alignment

Products that strengthen structural capability, diagnostics that improve acuity detection, AI systems that stabilise staffing, and monitoring systems that support 24/7 care gain economic relevance because they help hospitals maintain Leistungsgruppen qualification.

Products that do not contribute to capability may struggle, regardless of DRG impact.

DRGs no longer open the door to clinical activity.
Structural capability opens the door to DRGs.

This inversion redefines not only reimbursement mechanics but the economic logic of the German hospital landscape, the strategic priorities of hospital leadership, and the market-entry dynamics for medtech, diagnostics, digital health, and AI companies.

Evidence Behind Leistungsgruppen

The German hospital reform 2025 is not simply an administrative restructuring. It is anchored in a substantial body of health-services research demonstrating that structural capability, minimum procedural volumes, and regional concentration of expertise produce measurably better clinical and economic outcomes. The Leistungsgruppen model therefore reflects a scientifically validated approach to delivering complex hospital care.

1. Minimum Volume Effects: Higher Volumes, Better Outcomes

Decades of international literature show that procedural volume is a powerful predictor of patient outcomes.

Key evidence:

Birkmeyer et al. (2002) demonstrated strong volume–outcome relationships across major surgeries.
Pieper et al. (2013) confirmed similar associations in the European context.
IQWiG Mindestmengen reports (2019–2023) found that minimum volumes are associated with reduced perioperative mortality, fewer complications, and more stable quality across hospitals.

These findings justify why Leistungsgruppen require hospitals to reach minimum annual case thresholds. Under the German hospital reform 2025, volume is explicitly linked to eligibility for DRG billing, ensuring that only capable centres deliver high-risk procedures.

2. Structural Quality and Patient Safety

Structural capability affects outcomes even when procedural volumes are adequate. Research by IQTiG consistently shows that deficiencies in structural quality increase mortality and complication rates in:

Sepsis care, where delays in recognition and escalation significantly worsen outcomes
Stroke, particularly when neurologists and neuroimaging capacity are not continuously available
Major trauma, where survival depends on multidisciplinary and time-critical capability
Paediatric surgery, where specialist availability and equipment determine procedural safety

These findings underpin the Leistungsgruppen criteria related to:

24/7 specialist staffing
specific equipment standards
multidisciplinary integration
emergency readiness

The reform shifts Germany toward a capability-based guarantee of safety, rather than relying solely on DRG coding and documentation.

3. Regionalisation: European Evidence for Concentration of Complex Care

The German hospital reform 2025 reflects a broader European consensus that high-complexity care should be centralised in hospitals with proven infrastructure, expertise, and workforce depth.

Countries such as:

Sweden
Denmark
The Netherlands
parts of France

have already implemented regionalisation policies that concentrate complex surgery, trauma care, cardiology, and oncology in centres with stronger structural capability.

Documented benefits include:

Higher survival rates, particularly in time-sensitive conditions
Improved cost-efficiency, due to economies of scale
More stable specialist staffing patterns
Greater adherence to clinical guidelines
Reduced unwarranted variation in care quality

Germany’s move to Leistungsgruppen aligns its hospital landscape with these proven models, replacing fragmented service distribution with a more coherent, capability-driven structure.

4. Why This Evidence Matters for Innovation and Market Access

Because the German hospital reform 2025 ties DRG eligibility directly to structural capability, scientific evidence now shapes not only clinical pathways but financial flows.

Innovations that:

improve early detection (e.g., sepsis diagnostics),
stabilise workflows (AI triage, predictive monitoring),
support staffing constraints, or
enhance multidisciplinary coordination

become economically relevant because they help hospitals maintain Leistungsgruppen compliance.

In this new system, scientific validity and health-economic value become inseparable from structural capability.

Implications for Innovation and Market Access in Germany

1. Technologies must strengthen structural capability, not only DRG margins

Hospitals will invest in technologies that help them:

Secure or maintain Leistungsgruppen
Meet minimum volume requirements
Meet staffing and quality criteria
Reduce MD audit risk
Support 24/7 service continuity

This places high strategic value on:

Rapid diagnostics (sepsis, AMR, oncology)
AI-driven imaging and triage
Predictive monitoring systems
Workflow optimisation tools
ICU and ED digital platforms

These tools become capability enablers, not just cost-saving devices.

2. The innovation market becomes narrower—but deeper

High-complexity DRGs will be performed in fewer hospitals, meaning innovators must:

Identify the correct Level II/III centres
Engage hospitals likely to retain complex Leistungsgruppen
Avoid sites that will lose structural eligibility

This increases efficiency in sales, training, and real-world evidence generation.

3. Evidence requirements shift for G-BA and procurement decisions

Traditional evidence elements must now be expanded. Innovators must include:

Structural capability modelling
Workforce efficiency data
Regional pathway integration
Quality and safety metrics
Contribution to meeting Leistungsgruppen criteria

This directly affects G-BA applications, NUB submissions, ZE negotiations, and hospital purchasing cases.

Impact on Diagnostics and Digital Health: How Technology Strengthens Structural Capability Under German Hospital Reform 2025

Under German Hospital Reform 2025, diagnostics and digital health technologies are no longer judged merely by their clinical accuracy or marginal DRG effects. Their strategic relevance now depends on how effectively they strengthen a hospital’s structural capability, the essential prerequisite for holding and maintaining Leistungsgruppen accreditation. Technologies that improve diagnostic speed, operational consistency, workforce efficiency, and pathway integration are now direct enablers of DRG eligibility. In this new environment, diagnostics and digital tools shift from being “adjuncts to care” to becoming infrastructure for institutional survival in higher-level services.

Sepsis, AMR, and Acute-Infection Diagnostics: Anchoring High-Acuity Capability

Sepsis and antimicrobial resistance (AMR) diagnostics remain the most visible example of structural capability reinforcement. Early pathogen detection reduces:

time-to-appropriate therapy (TTAT)
septic shock mortality
ICU stay duration
inappropriate antibiotic exposure
ED congestion and bed bottlenecks

Every hour of delay in effective treatment increases sepsis mortality by 6–8% a statistic that underscores why rapid diagnostics are effectively a structural requirement for emergency and intensive care Leistungsgruppen. Faster organism identification stabilises patient flow across the ED–ward–ICU continuum, a key performance indicator in structural audits. Under the new rules, infection diagnostics are no longer “helpful”: they are proof of high-acuity readiness.

Broader Infectious Disease IVDs: Respiratory Panels, GI Panels, Meningitis/Encephalitis, and Viral Diagnostics

Beyond sepsis and AMR, a wide range of infectious-disease IVDs reinforce structural capability:

Respiratory pathogen panels (including influenza, RSV, SARS-CoV-2)

These enable rapid cohorting, prevent nosocomial spread, and support ED decompression during seasonal surges—critical to maintaining emergency Leistungsgruppen.

GI and enteric pathogen panels

Rapid isolation decisions reduce unit-wide disruption and support infection-control performance indicators within structural assessments.

Meningitis/encephalitis molecular panels

These reduce diagnostic uncertainty in high-risk neurological presentations, enabling earlier targeted therapy and supporting Level-II/III neurology and acute medicine Leistungsgruppen.

Blood-culture alternative platforms

Non-culture sepsis diagnostics (e.g., molecular or proteomic systems) deliver faster actionable results, strengthening critical-care infrastructure.

In the context of structural capability, these diagnostics demonstrate that a hospital possesses real-time infectious-disease readiness, a requirement in several high-acuity Leistungsgruppen.

Oncology Diagnostics: Molecular Profiling, Companion Diagnostics, and Early Detection

Oncology services are among the most structurally demanding Leistungsgruppen, requiring:

multidisciplinary tumour boards
molecular and genomic profiling
precision-therapy decision frameworks
continuous specialist availability
participation in certified cancer networks

Therefore, oncology diagnostics, including tissue-based NGS, liquid biopsies, immunohistochemistry (IHC), PCR-based markers (e.g., BRAF, EGFR, ESR1), and minimal residual disease (MRD) assays, directly reinforce structural capability by:

ensuring guideline-concordant therapeutic selection
supporting early detection and risk stratification
clarifying tumour subtype and prognosis
enabling access to G-BA-approved targeted therapies
integrating pathology, radiology, and medical oncology workflows

Digital pathology and computational imaging tools further increase diagnostic accuracy and reduce variation—two indicators evaluated in structural audits.

Thus, oncology diagnostics are not simply clinical tools; they are structural assets required to maintain cancer Leistungsgruppen.

Cardiology Diagnostics: Troponins, BNP/NT-proBNP, D-dimer, Imaging-Adjunct AI, and Stroke Pathway Tools

Emergency cardiology and stroke services depend heavily on time-critical diagnostics, including:

high-sensitivity troponins
BNP/NT-proBNP for heart failure
D-dimer and CT angiogram workflows
stroke imaging AI (LVO detection)
prehospital ECG triage and tele-cardiology

Rapid cardiac and neurological diagnostics support:

early rule-in/rule-out
faster thrombolysis/thrombectomy activation
improved resource allocation
reduced unnecessary admissions

Under the reform, cardiology and stroke Leistungsgruppen demand verifiable pathway speed, continuous specialist backup, and reliable workflows—conditions strengthened by diagnostic precision and digital decision support.

POCT (Point-of-Care Testing): Strengthening Emergency, Perioperative, and Ambulatory Leistungsguppen

POCT supports structural capability by providing immediate results in:

ED triage
perioperative assessment
acute medical wards
rural or Level-I facilities where labs are less accessible

Examples include:

bedside blood gases
lactate
glucose/ketone monitoring
coagulation (INR)
cardiac biomarkers

POCT reduces turnaround time, stabilises patient flow, and supports risk classification—improving structural performance for emergency and perioperative care.

Digital Coordination Platforms: Regional Integration and Network Readiness

Structural eligibility now requires hospitals to show:

participation in regional networks
transparent referral pathways
interoperable care systems
continuity across sectors

Digital platforms deliver:

automated referral and triage
real-time capacity management
cross-site data access
shared care plans
performance monitoring dashboards

European evidence (Denmark, Sweden, Netherlands) shows measurable improvements in:

timeliness of escalation
reduction of duplicate diagnostics
lower avoidable admissions
pathway consistency

Digital coordination is therefore a non-negotiable component of structural competence.

AI-Driven Triage, Decision Support, and Imaging Analytics: Workforce Multipliers

Germany’s workforce shortages make AI clinically and structurally relevant. AI improves:

early detection of deterioration (sepsis, stroke, PE, respiratory failure)
diagnostic throughput in radiology and pathology
prioritisation of cases
guideline adherence
intershift consistency

AI does not replace staff; it amplifies functional capability, satisfying Leistungsgruppen requirements for continuity and speed even in understaffed environments.

Predictive Monitoring and Early Warning Systems: Operational Stability as a Structural Asset

Predictive analytics reinforce:

patient-safety metrics
throughput stability
early detection of deterioration
reduction in ICU transfers
improved nursing workload distribution

These align with structural requirements around:

24/7 readiness
continuous monitoring
risk-management infrastructure
quality-assurance evidence

Predictive systems serve as institutional stabilisers, strengthening a hospital’s ability to maintain its Leistungsgruppe classification over time.

Structural Capability Value: The New Currency of Innovation

Under German Hospital Reform 2025, diagnostics and digital technologies must now demonstrate:

clinical value
operational value
structural capability value
regional integration value
workforce substitution value
eligibility preservation value

Technologies that support these components become strategically indispensable.
They determine who stays in Level II and III care, who gains access to high-value DRGs, and who is structurally downgraded.

Diagnostics and digital health tools are now part of the institutional backbone, not accessories to clinical care.

What the German Hospital Reform 2025 Means for the Period 2025–2030

Case Volumes Will Migrate Toward Structurally Capable Centres

Between 2025 and 2030, Germany will undergo a systematic reallocation of case volumes, particularly for high-complexity procedures in cardiology, oncology, trauma, neurosurgery, and intensive care. Because Leistungsgruppen now determine DRG eligibility, only Level II and Level III hospitals with verified structural capability will retain authorisation for complex services. This means patient flows will increasingly migrate toward hospitals with:

continuous specialist coverage
minimum-volume compliance
advanced diagnostics and digital infrastructure
integrated emergency and intensive care capability

Studies such as Birkmeyer (NEJM) and IQWiG Mindestmengen reports confirm that concentrating complex care improves mortality and long-term outcomes. The reform accelerates this trend by linking reimbursement directly to capability rather than activity.

SEO reinforcement: German Hospital Reform 2025 case volumes, Leistungsgruppen migration, DRG eligibility redistribution.

Smaller Hospitals Will Restructure Their Service Portfolios

Hospitals that cannot meet the structural requirements for higher-level Leistungsgruppen will pivot toward Level I services, especially low-acuity, high-volume pathways. By 2030, many community hospitals are expected to prioritise:

geriatrics and frailty management
rehabilitation and post-acute services
palliative care
ambulatory and chronic disease management
observation and stabilisation units

This shift reflects a structural reality: under the new hospital financing model, maintaining high-complexity DRGs requires investment in staffing, diagnostics, infrastructure, and emergency readiness that many smaller hospitals cannot sustain. WHO and OECD analyses show that countries with similar reforms rebalanced their hospital sectors toward differentiated roles rather than universal acute-care capability.

SEO reinforcement: hospital restructuring Germany, Level I hospitals, chronic care focus under the German hospital reform.

DRG Activity Will Reflect Structural Authorisation—Not Local Disease Incidence

One of the most profound consequences of the German Hospital Reform 2025 is that DRG distribution will no longer track population incidence. Instead, DRG activity will reflect which hospitals hold the required Leistungsgruppe accreditation. This is a fundamental departure from two decades of DRG-driven policy.

Examples:

A local rise in STEMIs does not mean a local hospital may bill PCI DRGs unless it holds the cardiology Leistungsgruppe.
A hospital cannot perform complex oncological surgery simply because patients present with those conditions; only accredited centres are authorised.

This uncoupling of clinical demand from reimbursement access changes regional planning, patient routing, hospital partnerships, and emergency response logistics. Lang’s 2025 modelling work suggests this will create new clinical corridors where emergency services bypass structurally ineligible hospitals to maintain quality and safety standards.

SEO reinforcement: DRG eligibility Germany, structural capability vs incidence, Leistungsgruppen authorisation.

Technology Adoption Will Become More Selective but Far Deeper

Under the previous DRG system, technology adoption often occurred primarily to improve throughput, documentation quality, or DRG profitability. From 2025 onward, the question shifts from:

“Does this technology save money?”
to
“Does this technology strengthen our structural capability and preserve our Leistungsgruppe?”

This makes adoption selective but deeper:

Technologies that will see high adoption:

Rapid diagnostics (sepsis, AMR, respiratory, CNS infections)
Oncology molecular profiling platforms (NGS, liquid biopsy)
AI triage and imaging systems
Predictive analytics and deterioration-monitoring tools
Digital coordination platforms for regional networks
ICU and ED workflow automation systems

Technologies that may decline:

Tools offering marginal operational benefit without structural relevance
Devices optimised solely for DRG optimisation rather than capability improvement

Hospitals will now invest to maintain Leistungsgruppen eligibility, not just marginal financial gain. This directly links technology adoption to hospital financing strategy under the new DRG rules.

SEO reinforcement: technology adoption Germany hospital reform, diagnostics structural capability, AI in German healthcare 2025.

G-BA Decisions Will Interact With Structural Eligibility

A positive G-BA (Gemeinsamer Bundesausschuss) benefit assessment remains essential for nationwide coverage, but it no longer guarantees that a hospital may offer the service. Under the reform:

G-BA determines scientific benefit and coverage
Leistungsgruppen determine which hospitals may deliver the service

This introduces a new dual-layer gatekeeping system:

Even if the G-BA approves:

A therapy, diagnostic, or medical device may only be used in hospitals meeting the structural capability thresholds.
Exams, interventions, or procedures may only be reimbursed if performed in structurally accredited centres.

For example, a high-cost oncology therapy with strong evidence cannot be delivered in a hospital lacking the oncology Leistungsgruppe. Similarly, rapid diagnostics approved by G-BA may become mandatory in Level II/III centres to maintain pathway speed requirements.

This marks a major shift in German HTA implementation, moving from evidence-based coverage to capability-based operationalisation. WHO’s 2025 review calls this “a fundamental redefinition of how evidence translates into service delivery.”

SEO reinforcement: G-BA and Leistungsgruppen, G-BA DRG eligibility interaction, German HTA system 2025.

A New Centre of Gravity in German Reimbursement

The German hospital reform 2025 replaces a DRG-centric financing model with a structural-capability governance system, in which reimbursement follows verified institutional competence rather than coded activity. Eligibility for specialised care now depends on whether a hospital can demonstrate the minimum volumes, staffing, infrastructure, and integrated pathways required by the relevant Leistungsgruppe. DRGs become the output of structural qualification, not the driver of it.

This shift has profound implications for innovation, economics, and market access.
For innovators across medtech, diagnostics, AI, and digital health:

Market access now requires both scientific evidence and structural alignment.
A technology must contribute to maintaining or strengthening a hospital’s Leistungsgruppe eligibility—not merely improve DRG margins.
Adoption will increasingly concentrate in Level II and Level III centres, where complex care is structurally anchored and financially protected.
These centres will become the primary engines of innovation diffusion, evidence generation, and procurement.
Winning strategies position technologies as capability enablers, demonstrating clear impact on staffing efficiency, pathway quality, minimum volume attainment, and readiness for 24/7 service delivery.

Under the new model, success in Germany depends on understanding not only how the DRG system works, but who is still allowed to use it. The economics of reimbursement, the geography of care, and the logic of investment have all shifted.

The market has changed.
Strategies must evolve with it.

REFERENCE LIST

Policy & Regulatory Framework

Federal Ministry of Health (BMG). Hospital Reform 2025 – Overview.
Defines the core structural-capability model, Leistungsgruppen, and financing reform.
https://www.bundesgesundheitsministerium.de/en/topics/hospital/hospital-reform.html

German Bundestag. Krankenhausversorgungsverbesserungsgesetz (KHVVG).
Legislative basis for Leistungsgruppen, hospital level assignments, and transition measures.
https://dserver.bundestag.de/btd/20/112/20112.pdf

WHO European Observatory. Analysis of the Hospital Care Improvement Act (2025).
Independent policy assessment confirming Germany’s shift from activity-based financing to structural governance.
https://eurohealthobservatory.who.int/monitors/health-systems-monitor/analyses/hspm/germany-2020/the-hospital-care-improvement-act-came-into-force-on-1-january-2025

Structural Quality, Minimum Volumes & Outcomes

IQWiG. Mindestmengen Evidence Summaries (2019–2023).
Scientific justification for minimum volumes, showing reduced mortality in high-complexity care.
https://www.iqwig.de/en/projects/mindestmengen/

IQTIG. Quality Assurance Reports (QI & Structural Data).
Demonstrates the link between structural readiness and outcomes in sepsis, stroke, trauma, and paediatric surgery.
https://iqtig.org/berichte/

Birkmeyer JD et al. Hospital Volume and Surgical Mortality. NEJM, 2002.
Foundational evidence that higher procedural volume reduces operative mortality.
https://www.nejm.org/doi/full/10.1056/NEJMsa012337

Pieper D et al. Systematic Review of Volume–Outcome Relationships in Europe.
Meta-analysis confirming lower mortality in high-volume hospitals across specialties.
https://pubmed.ncbi.nlm.nih.gov/23731513/

Diagnostics, Acute Care & Time-Critical Pathways

Walkey AJ et al. Volume and Outcomes in Severe Sepsis. AJRCCM, 2014.
High-volume centres show significantly lower sepsis mortality—supports centralisation logic.
https://www.atsjournals.org/doi/full/10.1164/rccm.201311-1967OC

Liu VX et al. Timing of Early Antibiotics and Hospital Mortality in Sepsis. CCM, 2017.
Each hour of diagnostic and treatment delay increases mortality by 6–8%.
https://pubmed.ncbi.nlm.nih.gov/28333758/

Surviving Sepsis Campaign 2021 Guidelines.
Global benchmark for time-sensitive diagnosis and early intervention pathways.
https://journals.lww.com/ccmjournal/Fulltext/2021/11000/Surviving_Sepsis_Campaign.21.aspx

T2Bacteria Rapid Diagnostics Study (2020).
Demonstrates clinical utility of ultra-rapid bloodstream infection detection for ICU readiness.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483183/

Oncology & Precision Diagnostics

Nature Reviews Genetics (2021). Liquid Biopsy, MRD and Molecular Profiling Review.
Establishes diagnostics as a structural requirement for precision oncology pathways.
https://www.nature.com/articles/s41576-021-00366-4

AI, Digital Health & Workforce Augmentation

AI Triage and Sepsis Prediction Meta-analysis (2022).
Shows AI improves early detection, reduces ICU transfers, and offsets specialist shortages.
https://pubmed.ncbi.nlm.nih.gov/35234589/

OECD. Health at a Glance Europe (2023–2024).
Evidence on Germany’s workforce shortages and structural-system pressures.
https://www.oecd.org/health/health-at-a-glance-europe/

System Transparency & Structural Capability Assessment

BMG. Hospital Transparency Act (Krankenhaustransparenzgesetz).
Introduces public reporting of structural quality, staffing levels, and service capability.
https://www.bundesgesundheitsministerium.de/en/topics/hospital/hospital-transparency-act.html

Sule U, Busse R, Heidecke C-D et al. Germany’s Hospital Transparency Act – System-Level Implications. SSRN, 2025.
Shows how transparency, structural quality, and Leistungsgruppen eligibility intersect.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5361656

Economic Modelling & Forecasts

Lang S. (2025). Simulation of the Effects of the KHVVG on Hospital Structure and Financing.
Modelling predicts consolidation patterns, shifts in DRG access, and financial impact through 2030.
https://pubmed.ncbi.nlm.nih.gov/40434670/

Simon-Kucher (2025). What the German Hospital Reform Means for MedTech.
Explains commercial impact: concentrated demand, capability-driven adoption, and market redistribution.
https://www.simon-kucher.com/de/insights/die-deutsche-krankenhausreform-2025-was-sie-fuer-medizintechnikunternehmen-bedeutet

Frequently Asked Questions (FAQ): German Hospital Reform 2025, DRG Eligibility & Leistungsgruppen

Why Was the German Hospital Reform 2025 Introduced, and What Systemic Problems Does It Solve?

The German Hospital Reform 2025 was introduced to correct deep structural imbalances caused by two decades of DRG-based financing, which rewarded activity rather than capability. Under the old system, any hospital could bill almost any DRG if its coding and documentation were accurate, regardless of whether it had the equipment, staffing, or specialist availability required to provide high-risk care safely. This produced significant variation in outcomes, wide duplication of services across neighbouring hospitals, and rising financial instability. According to OECD’s Health at a Glance Europe, Germany maintained one of the highest hospital densities in Europe, yet mortality for time-sensitive conditions such as sepsis, stroke, and trauma remained highly variable.

By 2024, more than half of hospitals were reporting structural deficits, with Länder investment failing to keep pace with capital needs. Meanwhile, IQTIG quality reports showed that hospitals lacking structural capability—insufficient intensivists, lack of 24/7 specialists, inadequate monitoring—were consistently associated with higher mortality. The reform therefore shifts Germany toward a structural-capability model, confirmed by the WHO European Observatory, where reimbursement depends on verified readiness, minimum volumes, and integrated pathways. This marks the most consequential restructuring of German hospital financing since 2003.

What Are Leistungsgruppen and Why Are They Central to DRG Eligibility Under the Reform?

Leistungsgruppen are structured service groups that classify hospitals according to their verified capacity to provide specific categories of care. They serve as the new gatekeeping mechanism for DRG eligibility. Unlike DRGs, which function purely as billing instruments, Leistungsgruppen determine whether a hospital is authorised to perform a service at all. To hold a Leistungsgruppe, a hospital must demonstrate minimum annual case volumes supported by outcome-based evidence (as shown in IQWiG’s Mindestmengen analyses and by Birkmeyer’s NEJM study), continuous specialist availability, defined equipment standards, and integration into regional care networks.

This approach aligns Germany with Scandinavian and Dutch health-system models, where structural capability—not billing rules—determines eligibility to deliver complex care. WHO’s 2025 analysis highlights that Leistungsgruppen ensure high-acuity services are concentrated in institutions with the infrastructure, workforce depth, and clinical readiness to deliver them safely. For hospital leadership, this shifts strategic focus from optimising DRG revenue to sustaining the structural capability required to maintain authorisation.

How Does the German Hospital Reform 2025 Change DRG Eligibility, and Why Is This Reversal So Important?

Before 2025, DRG eligibility was determined by coding accuracy, documentation quality, and MD audit compliance. This meant that any hospital could bill high-complexity DRGs—such as PCI, major oncology surgery, trauma care, or intensive care pathways—even if its structural capability was limited. The German Hospital Reform 2025 reverses this logic entirely: now, hospitals may only bill a DRG if they already hold the corresponding Leistungsgruppe. This ensures that only structurally capable institutions deliver high-risk care.

The significance of this shift cannot be overstated. Volume–outcome literature—from Pieper’s European meta-analysis to Walkey’s sepsis studies—shows that low-volume hospitals have higher mortality. IQTIG data confirm structural deficits are a leading contributor to poor outcomes. Economically, the reform redistributes DRG revenue toward capable Level II and III hospitals and reduces insolvency risk by preventing strategic overextension in low-capability centres. Modelling by Lang (2025) predicts consolidation of cardiology, oncology, trauma, and orthopaedic services, creating a more rationalised, evidence-aligned hospital landscape.

How Do Diagnostics, IVDs, Rapid Testing, and Laboratory Infrastructure Influence Structural Capability?

Diagnostics now underpin structural capability in Germany. Under the new reform, rapid testing, IVD platforms, and laboratory infrastructure are essential for maintaining Leistungsgruppen in emergency medicine, intensive care, oncology, and infectious-disease pathways. Sepsis studies, such as those by Liu in Critical Care Medicine, show that every hour of delay in appropriate therapy increases mortality by 6–8%. Rapid diagnostics—including AMR panels, respiratory multiplex assays, bloodstream infection systems, and meningitis/encephalitis molecular panels—reduce diagnostic uncertainty and improve outcome trajectories.

In oncology, access to molecular profiling, NGS panels, liquid biopsy, and companion diagnostics is now required to maintain high-level cancer Leistungsgruppen, supporting guideline-concordant tumour board decisions. Even point-of-care tests such as blood gases, lactate, troponins and INR show structural readiness by enabling continuous acute assessment. WHO and Simon-Kucher analyses emphasise that diagnostics are now core eligibility infrastructure, not “testing tools”, because they allow hospitals to demonstrate pathway speed, acuity readiness, and minimum-volume safety.

Why Are AI Triage Systems, Predictive Analytics, and Digital Coordination Platforms Critical Under the New Financing Model?

Digital tools have become essential enablers of structural capability, particularly in a health system confronting severe workforce shortages. AI-based triage tools identify high-risk patients earlier—detecting sepsis, stroke, respiratory failure, or haemodynamic instability—reducing time-to-diagnosis and stabilising clinical operations. A meta-analysis of AI sepsis prediction demonstrates reduced ICU transfers and fewer sentinel events, reinforcing the platform’s structural value. Predictive analytics improve early-warning capabilities, prevent avoidable escalations, and optimise nursing workloads—all documented contributors to performance in IQTIG structural assessments.

Digital coordination platforms are equally central because Leistungsgruppen criteria require hospitals to demonstrate real participation in regional care networks. Evidence from Denmark, Sweden and the Netherlands shows that coordinated referral systems reduce duplication of diagnostics, enhance escalation timeliness, and improve guideline adherence. These digital tools provide measurable proof of integrated care pathways—one of the reform’s most important structural metrics. For German hospitals, investing in digital health is now a requirement for maintaining higher Leistungsgruppen and the DRG access that comes with them.

What Does the Reform Mean for MedTech, Diagnostics, and Digital Health Companies Entering the German Market?

The reform marks a commercial turning point for innovators. The market is becoming narrower but deeper: fewer hospitals will deliver high-complexity services, but those that remain will have higher volumes, more stable staffing, and stronger financial incentives to invest in capability-enabling technologies. As the Simon-Kucher 2025 report notes, innovations that demonstrate structural value—helping hospitals achieve minimum volumes, maintain specialist readiness, meet acute-care timing standards, or integrate into regional networks—will have significantly higher adoption potential.

Technologies without structural relevance may struggle, even if they demonstrate strong clinical or economic benefits. Innovators must now present evidence packages that show contribution to Leistungsgruppen eligibility, not merely DRG optimisation or cost savings. Post-market evidence must include pathway performance, operational efficiency, workforce impact, and readiness improvements. The German market is transitioning into one where adoption is driven by capability economics, not transactional procurement.

What Are the Long-Term Implications of Leistungsgruppen for Hospital Networks, Patient Outcomes, and Equity of Access?

Long-term, Leistungsgruppen will reshape the German hospital landscape by concentrating high-acuity care in Level II and III centres, reducing unwarranted variation, and improving outcomes for complex conditions—patterns confirmed across Europe by OECD and WHO analyses. Higher-volume centres typically achieve lower mortality for cardiac interventions, cancer surgery, trauma care, and sepsis, consistent with the findings of Birkmeyer, Pieper, and Walkey. Smaller hospitals will transition toward geriatrics, rehabilitation, chronic care, and ambulatory services, forming more structured regional ecosystems.

Equity of access will depend on whether regional networks—including digital referral platforms—ensure timely escalation. Evidence from Scandinavian systems suggests that when integrated properly, centralisation can improve both quality and equity. However, the success of Germany’s system will depend on transport infrastructure, telemedicine integration, and effective capacity management across networks. If implemented well, Leistungsgruppen could create a system where structural capability, not geography, determines the quality of care patients receive.

How Can Hospitals Maintain Leistungsgruppen Eligibility and Avoid Losing Access to High-Value DRGs?

Hospitals must undertake ongoing structural capability monitoring. This includes tracking minimum volumes, specialist staffing patterns, diagnostic turnaround times, ICU readiness indicators, regional referral metrics, and adherence to evidence-based pathways. The Hospital Transparency Act mandates public reporting of structural and staffing metrics, meaning capability gaps become visible to patients, insurers, and regulatory bodies. Regular internal audits, supported by digital dashboards and pathway analytics, will be essential.

Hospitals that fail to maintain eligibility risk losing access to high-value DRGs—a threat that could create severe financial instability. As Lang’s modelling work demonstrates, maintaining Leistungsgruppen requires continuous investment in workforce, diagnostics, digital infrastructure, and pathway optimisation. For many institutions, strategic partnerships with innovators may become essential to sustaining eligibility. The reform rewards hospitals that continuously strengthen capability and penalises those that rely on legacy DRG logic.

German Hospital Reform 2025: how to secure DRG Eligibility